Syntekabio to Showcase Innovative AI Drug Discovery Technologies at Bio-IT World
11 avr. 2024 10h15 HE
|
Syntekabio USA Inc.
NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- Syntekabio (226330.KQ), a global artificial intelligence (AI) drug discovery pioneer, today announced its participation at the upcoming Bio-IT World...
Understanding Pharmacovigilance Regulations in Asia-Pacific Training Course (Online Event, July 8-9, 2024)
04 avr. 2024 07h47 HE
|
Research and Markets
Dublin, April 04, 2024 (GLOBE NEWSWIRE) -- The "Understanding Pharmacovigilance Regulations in APAC Training Course" conference has been added to ResearchAndMarkets.com's offering. ...
Pattern to Participate in Life Science Innovation Northwest 2024 Conference
03 avr. 2024 16h55 HE
|
PATTERN COMPUTER, INC.
REDMOND, Wash., April 03, 2024 (GLOBE NEWSWIRE) -- Pattern Computer®, Inc. (“Pattern” or “the Company”) today announced that Mark R. Anderson, Chairman and CEO, Matt Keener, CTO, and Nidhi Singh,...
Contract Research Organization Services (CROs) Global Strategic Research Report 2024: Market to Reach $149.1 Billion by 2030 - CROs to Leverage Artificial Intelligence in a Major Way
03 avr. 2024 07h52 HE
|
Research and Markets
Dublin, April 03, 2024 (GLOBE NEWSWIRE) -- The "Contract Research Organization Services (CROs) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global...
Global Recombinant Proteins Market Report - Growth Factors & Chemokines Segment to Dominate Market During Forecast Period 2024-2028
02 avr. 2024 11h52 HE
|
Research and Markets
Dublin, April 02, 2024 (GLOBE NEWSWIRE) -- The "Global Recombinant Proteins Market by Product (Growth Factors, Chemokines, Structural Proteins, Membrane Proteins), Application (Drug Discovery &...
Global Active Pharmaceutical Ingredient CDMO Market Projected to Reach USD 164.5 Billion by 2030
29 mars 2024 05h36 HE
|
Research and Markets
Dublin, March 29, 2024 (GLOBE NEWSWIRE) -- The "Active Pharmaceutical Ingredient CDMO Market Size, Share & Trends Analysis Report By Product, By Synthesis, By Drug, By Application, By Workflow,...
Larkspur Biosciences to Present New Preclinical Research on Lead Development Program Candidate, a First-in-Class PIP4K2C Protein Degrader, at AACR 2024
28 mars 2024 08h00 HE
|
Larkspur Biosciences, Inc.
Larkspur Biosciences to Present New Preclinical Research on Lead Development Program Candidate, a First-in-Class PIP4K2C Protein Degrader, at AACR 2024
CHARM Therapeutics Announces Foundation of Scientific Advisory Board (SAB)
19 mars 2024 10h00 HE
|
Charm Therapeutics
PRESS RELEASE CHARM Therapeutics Announces Foundation of Scientific Advisory Board (SAB) LONDON – 19 March 2024 -- CHARM Therapeutics (“CHARM”, “The Company”), a 3D deep-learning research company...
UPDATE – Pattern to Present at 23rd Annual Needham Virtual Healthcare Conference
18 mars 2024 10h30 HE
|
PATTERN COMPUTER, INC.
REDMOND, Wash., March 18, 2024 (GLOBE NEWSWIRE) -- Pattern Computer®, Inc. (“Pattern” or “the Company”) today announced that Mark R. Anderson, Chairman and CEO, will participate in the 23rd Annual...
Pattern to Present at 23rd Annual Needham Virtual Healthcare Conference
18 mars 2024 08h30 HE
|
PATTERN COMPUTER, INC.
REDMOND, Wash., March 18, 2024 (GLOBE NEWSWIRE) -- Pattern Computer®, Inc. (“Pattern” or “the Company”) today announced that Mark R. Anderson, Chairman and CEO, will participate in the 23rd Annual...